Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Scott Russell
Observed name:
Russell, Scott
Institution:
Aridhia (United Kingdom)
Observed institution:
Aridhia (United Kingdom)
ORCID:
0009-0007-2202-3173
Observed ORCID:
0009-0007-2202-3173
OpenAlex ID:
A5080341016
The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP)
2023
·
Jeffrey S. Barrett
, Alexandre Betourne
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
25
PDF
Digital Research Environment(DRE)-enabled Artificial Intelligence (AI) to facilitate early stage drug development
2023
·
Jeffrey S. Barrett
, Solmaz Eradat Oskoui
, et al.
·
Frontiers in Pharmacology
·
11
PDF
Bringing platform trials closer to reality by enabling with digital research environment (DRE) connectivity
2024
·
Jeffrey S. Barrett
, Kara Lasater
, et al.
·
Contemporary Clinical Trials
·
2
Aridhia DRE 2026 SATRE Assessment
2026
·
Stiven, Ross
, Russell, Scott
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Crowdsourcing Proposal Supporting Patient Engagement in Parkinson's Disease: A Digital Research Environment (DRE)‐Enabled, Patient Swarm Approach to Develop QSP Models
2025
·
Jeffrey S. Barrett
, Benedetto Piccoli
, et al.
·
The Journal of Clinical Pharmacology
PDF
Aridhia DRE 2025 SATRE Assessment
2025
·
Shishodia, Laura
, Stiven, Ross
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
19 Open-science solutions enabled within a digital research environment to support pediatric drug development and precision dosing
2024
·
Jeff Barrett
, Scott Russell
·
BMJ Paediatrics Open
PDF
Open-Science Solutions Enabled within a Digital Research Environment to Support Midd (Model Informed Drug Development) and Precision Dosing
2024
·
Scott Russell
, Janani Murthy
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
9
Citation count:
38
H-index:
2
I10-index:
2
Year
Topic
Type
